Gene expression in splenic CD4 and CD8 cells from BALB/c mice immunized with Porphyromonas gingivalis

Journal of Periodontology

Volumn 77, Issue 4, 2006, Pages 622-633

  Gemmell, Erica ^a   Drysdale, Karen E ^a   Seymour, Gregory J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

CD4; CD8; Mice; Microarray; Porphyromonas gingivalis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; FREUND ADJUVANT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN HEAVY CHAIN; OUTER MEMBRANE PROTEIN; PHOSPHATE; SODIUM CHLORIDE; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL SEPARATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC CODE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MICROARRAY ANALYSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PROTEIN BINDING; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOCOMPETENCE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PERIODONTITIS; PROTEIN MICROARRAY; SPLEEN;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; FEMALE; GENE EXPRESSION; IMMUNOCOMPETENCE; IMMUNOPROTEINS; MICE; MICE, INBRED BALB C; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN ARRAY ANALYSIS; SPLEEN;

EID: 33646905389     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050211     Document Type: Article

References (79)

1. Zadeh HH, Nichols FC, Miyasaki KT. The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis. Periodontol 2000 1999;20:239-288.
2. Seymour GJ, Greenspan JS. The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. J Periodontal Res 1979; 14:39-46.
3. Seymour GJ, Gemmell E, Walsh LJ, Powell RN. Immunohistological analysis of experimental gingivitis in humans. Clin Exp Immunol 1988;71:132-137.
4. Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 2002; 13:17-34.
5. Okada H, Ito H, Harada Y. T-cell requirement for establishment of the IgG-dominant B-cell lesion in periodontitis. J Periodontal Res 1987;22:187-189.
6. Taubman MA, Stoufi ED, Ebersole JL, Smith DJ. Phenotypic studies of cells from periodontal disease tissue. J Periodontal Res 1984;19:587-590.
7. Cole KL, Seymour GJ, Powell RN. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues. J Periodontol 1987;58:569-573.
8. Seymour GJ, Cole KL, Powell RN. Analysis of lymphocyte populations extracted from chronically inflamed human periodontal tissues. II. Blastogenic response. J Periodontal Res 1985;20:571-579.
9. Cole KC, Seymour GJ, Powell RN. The autologous mixed lymphocyte reactions (AMLR) using periodontal lymphocytes. J Dent Res 1986:65:473 (Abstr. 16).
10. Seymour GJ, Cole KL, Powell RN, Lewins E, Cripps AW, Clancy RL. Interleukin-2 production and bone resorption activity by unstimulated lymphocytes extracted from chronically inflamed human periodontal tissues. Arch Oral Biol 1985;30:481-484.
11. Bird PS, Seymour GJ. Production of monoclonal antibodies that recognise specific and cross-reactive antigens of Fusobacterium nucleatum. Infect Immun 1987;55:771-777.
12. Gemmell E, Polak B, Reinhardt RA, Eccleston J, Seymour GJ. Antibody responses of Porphyromonas gingivalis infected gingivitis and periodontitis subjects. Oral Dis 1995;1:63-69.
13. Gemmell E, Winning TA, Bird PS, Seymour GJ. Cytokine profiles of lesional and splenic T cells in Porphyromonas gingivalis infection in a murine model. J Periodontol 1998;69:1131-1138.
14. Gemmell E, Carter CL, Grieco DA, Sugerman PB, Seymour GJ. P. gingivalis-specific T cell lines produce Th1 and Th2 cytokine. J Dent Res 2002;81:303-307.
15. Hirokawa M, Kitabayashi A, Kuroki J, Miura AB. Signal transduction by B7/ BB1 expressed on activated T lymphocytes: Cross-linking of B7/BB1 induces protein tyrosine phosphorylation and synergizes with signalling through T-cell receptor/CD3. Immunology 1995;86:155-161.
16. Gemmell E, Grieco DA, Seymour GJ. Chemokine expression in Porphyromonas gingivalis-specific T-cell lines. Oral Microbiol Immunol 2000;15:166-171.
17. Kobayashi-Sakamoto M, Isogai E, Hirose K. Porphyromonas gingivalis modulates the production of interleukin 8 and monocyte chemotactic protein 1 in human vascular endothelial cells. Curr Microbiol 2003; 46:109-114.
18. Wilhelmsen K, Burkhalter S, van der Geer P. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus. Oncogene 2002;21:1079-1089.
19. Chapple CC, Srivastava M, Hunter N. Failure of macrophage activation in destructive periodontal disease. J Pathol 1998;186:281-286.
20. Funauchi M, Yoo BS, Nozaki Y, et al. Dysregulation of the granulocyte-macrophage colony-stimulating factor receptor is one of the causes of defective expression of CD80 antigen in systemic lupus erythematosus. Lupus 2002;11:317-321.
21. Birkedal-Hansen H. Roles of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
22. Gemmell E, Seymour GJ. Cytokine profiles of cells extracted from human periodontal diseases. J Dent Res 1998;77:16-26.
23. Ivanyi L, Lehner T. Stimulation of lymphocyte transformation by bacterial antigens in patients with periodontal disease. Arch Oral Biol 1970;15:1089-1096.
24. Boyatzis S, Seymour GJ. Effect of age and periodontal disease status in man on the spontaneous proliferation of peripheral blood lymphocytes. Arch Oral Biol 1986;31:749-755.
25. Lye E, Mirtsos C, Suzuki N, Suzuki S, Yeh WC. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling. J Biol Chem 2004;279:40653-40658.
26. Suzuki N, Chen NJ, Millar DG, et al. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses. J Immunol 2003;170:4031-4035.
27. Lu B, Ebensperger C, Dembic Z, et al. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998;95:8233-8238.
28. Aviles Mendoza GJ, Seidel NE, Otsu M, et al. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model. Mol Ther 2001;3:565-573.
29. Kimura S, Fujimoto N, Okada H. Impaired autologous mixed-lymphocyte reaction of peripheral blood lymphocytes in adult periodontitis. Infect Immun 1991;59: 4418-4424.
30. Suzuki JB, Risom L, Falkler WA, Collison C, Bowers G. Effect of periodontal therapy on spontaneous lymphocyte response and neutrophil chemotaxis in localized and generalized juvenile periodontitis patients. J Clin Periodontol 1985;12:124-134.
31. Boulanger MJ, Chow DC, Brevnova EE, Garcia KC. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 2003; 300:2101-2104.
32. Oleksy A, Banbula A, Bugno M, Travis J, Potempa J. Proteolysis of interleukin-6 receptor (IL-6R) by Porphyromonas gingivalis cysteine proteinases (gingipains) inhibits interleukin-6-mediated cell activation. Microb Pathog 2002;32:173-181.
33. Pellegrini M, Bouillet P, Robati M, Belz GT, Davey GM, Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004;200:1189-1195.
34. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150: 353-360.
35. Howard M, O'Garra A. Biological properties of inter- leukin 10. Immunol Today 1992;13:198-200.
36. Lard LR, Roep BO, Verburgh CA, Zwinderman AH, Huizinga TW. Elevated IL-16 levels in patients with systemic lupus erythematosus are associated with disease severity but not with genetic susceptibility to lupus. Lupus 2002;11:181-185.
37. Gemmell E, Bird PS, Bowman JD, et al. Immunohistological study of Porphyromonas gingivalis-induced lesions in a murine model. Oral Microbiol Immunol 1997;12:288-297.
38. Kelly MN, Kolls JK, Happel K, et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect Immun 2005;73:617-621.
39. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol 2003;73:213-224.
40. Born TL, Thomassen E, Bird TA, Sims JE. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 1998;273:29445-29450.
41. Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H. Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer. Clin Cancer Res 2003;9:2357-2365.
42. Amendt C, Mann A, Schirmacher P, Blessing M. Resistance of keratinocytes to TGFbeta-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci 2002; 115:2189-2198.
43. Centrella M, McCarthy TL, Canalis E. Skeletal tissue and transforming growth factor β. FASEB J 1988;2: 3066-3073.
44. Gemmell E, Seymour GJ. Interleukin 1, interleukin 6 and transforming growth factor-beta production by human gingival mononuclear cells following stimulation with Porphyromonas gingivalis and Fusobacterium nucleatum. J Periodontal Res 1993;28:122-129.
45. Engel P, Zhou LJ, Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995; 3:39-50.
46. Otipoby KL, Andersson KB, Draves KE, et al. CD22 regulates thymus-independent responses and the life-span of B cells. Nature 1996;384:634-637.
47. Thompson AA, Wood WJ Jr., Gilly MJ, Damore MA, Omori SA, Wall R. The promoter and 5′ flanking sequences controlling human B29 gene expression. Blood 1996;87:666-673.
48. Mason DY, van Noesel CJ, Cordell JL, et al. The B29 and mb-1 polypeptides are differentially expressed during human B cell differentiation. Eur J Immunol 1992;22:2753-2756.
49. Mason DY, Cordell JL, Tse AG, et al. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells. J Immunol 1991;147:2474-2482.
50. Chong HJ, Andrew Bouton L, Bailey DP, et al. IL-4 selectively enhances FcgammaRIII expression and signaling on mouse mast cells. Cell Immunol 2003; 224:65-73.
51. Yada A, Ebihara S, Matsumura K. Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/ III -mediated immune complex uptake. Cell Immunol 2003;225: 21-32.
52. Collins JT, Dunnick WA. Germline transcripts of the murine immunoglobulin gamma 2a gene: Structure and induction by IFN-gamma. Int Immunol 1993;5: 885-891.
53. Elenich LA, Ford CS, Dunnick WA. The gamma 1 heavy chain gene includes all of the cis-acting elements necessary for expression of properly regulated germ-line transcripts. J Immunol 1996;157:176-182.
54. Wilkins AL, Yang W, Yang JJ. Structural biology of the cell adhesion protein CD2: From molecular recognition to protein folding and design. Curr Protein Pept Sci 2003;4:367-373.
55. Musgrave BL, Watson CL, Hoskin DW. CD2-CD48 interactions promote cytotoxic T lymphocyte induction and function: Anti-CD2 and anti-CD48 antibodies impair cytokine synthesis, proliferation, target recognition/ adhesion, and cytotoxicity. J Interferon Cytokine Res 2003;23:67-81.
56. Nishizawa K, Freund C, Li J, Wagner G, Reinherz EL. Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation. Proc Natl Acad Sci USA 1998;95:14897-14902.
57. Bocko D, Frydecka I. Structure and function of lymphocyte TCR/CD3 complex (in Polish). Postepy Hig Med Dosw 2003;57:519-529.
58. Nambiar MP, Fisher CU, Warke VG, et al. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3 induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 2003;48: 1948-1955.
59. Kenny E, Mason D, Pombo A, Ramirez F. Phenotypic analysis of peripheral CD4+ CD8+ T cells in the rat. Immunology 2000;101:178-184.
60. Torres-Nagel N, Kraus E, Brown MH, et al. Differential thymus dependence of rat CD8 isoform expression. Eur J Immunol 1992;22:2841-2848.
61. Kenny E, Mason D, Saoudi A, Pombo A, Ramirez F. CD8 alpha is an activation marker for a subset of peripheral CD4 T cells. Eur J Immunol 2004;34:1262-1271.
62. Seddon B, Mason D. Effects of cytokines and glucocorticoids on endogenous class II MHC antigen expression by activated rat CD4+ T cells. Mature CD4+ CD8- thymocytes are phenotypically heterogeneous on activation. Int Immunol 1996;8:1185-1193.
63. Mannie MD, Norris MS. MHC class-II -restricted antigen presentation by myelin basic protein-specific CD4+ T cells causes prolonged desensitization and outgrowth of CD4- responders. Cell Immunol 2001;212:51-62.
64. Bendelac A. Mouse NK1+ T cells. Curr Opin Immunol 1995;7:367-374.
65. Singh N, Hong S, Scherer DC, et al. Cutting edge: Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999;163: 2373-2377.
66. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005;23:197-223.
67. Mathur P, Murray B, Crowell T, et al. Murine peptidoglycan recognition proteins PglyrpIalpha and PglyrpI-beta are encoded in the epidermal differentiation complex and are expressed in epidermal and hematopoietic tissues. Genomics 2004;83:1151-1163.
68. Spitzer JH, Visintin A, Mazzoni A, Kennedy MN, Segal DM. Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells. Eur J Immunol 2002; 32:1182-1187.
69. Eng HL, Wang CH, Chen CH, Chou MH, Cheng CT, Lin TMA. CD14 promoter polymorphism is associated with CD14 expression and Chlamydia-stimulated TNF alpha production. Genes Immun 2004;5:426-430.
70. Takeuchi O, Sato S, Horiuchi T, et al. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002;169: 10-14.
71. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 2001;167:987-994.
72. Bleijs DA, de Waal Malefyt R, Figdor CG, van Kooyk Y. Co-stimulation of T cells results in distinct IL-10 and TNF-alpha cytokine profiles dependent on binding to ICAM-1, ICAM-2 or ICAM-3. Eur J Immunol 1999;29: 2248-2258.
73. Cutler SM, Garcia AJ. Engineering cell adhesive surfaces that direct integrin alpha5beta1 binding using a recombinant fragment of fibronectin. Biomaterials 2003;24:1759-1770.
74. Berndt C, Casaroli-Marano RP, Vilaro S, Reina M. Cloning and characterization of human syndecan-3. J Cell Biochem 2001;82:246-259.
75. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002;39:279-291.
76. White JM. ADAMs: Modulators of cell-cell and cell-matrix interactions. Curr Opin Cell Biol 2003;15:598-606.
77. Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001; 72:1398-1406.
78. Yoshioka M, Yokoyama N, Masuda K, et al. Effect of hydroxamic acid-based matrix metalloproteinase inhibitors on human gingival cells and Porphyromonas gingivalis. J Periodontol 2003;74:1219-1224.
79. Wang QT. The distribution and significance of collagen type III and fibronectin in human gingiva (in Chinese). Zhonghua Kou Qiang Yi Xue Za Zhi 1992; 27:336-338,384